Reinhard von Roemeling

Reinhard von Roemeling, MD, is an innovative leader of clinical research and global drug development.

He received his medical degree from the Goethe University Medical School in Frankfurt / Main – Germany. Board certifications in internal medicine, hematology and oncology. Clinical practice as faculty of academic institutions including Univ. of MN School of Medicine in Minneapolis, Albany Medical College, NY, and Fox Chase Comprehensive Cancer Center, Philadelphia, PA.

He has successfully directed global drug development programs of phases I-IV in positions of increasing responsibility at both pharmaceutical and biotech companies for more than 20 years, supporting several regulatory approvals of small molecule and biologic drugs. Special interest in clinical pharmacology, translational medicine, and biomarker-driven precision medicine in oncology.

Recent positions as SVP of Global Clinical Development – Oncology and Immuno-oncology at EMD-Serono/Merck KGaA and VP Global Clin. Dev. Hem/Onc. at Daiichi-Sankyo, Inc. Previous positions at Schering AG, Boehringer-Ingelheim, and Sanofi.

His core motivation as physician and researcher is developing transformational and potentially curative treatments for patients with life-threatening diseases.